This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit | Clinical Laboratory Marketplace    

Home   About   Scholarships   Meetings   Publications   Resources   Jul. 17, 2012


Scientists pinpoint antibody that may be specific
to MS patients

HealthDay    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have identified an antibody found in the blood of about half of patients with multiple sclerosis that is not found in people without the autoimmune disease. The implications of the antibody's presence aren't fully understood. But in rodents, the antibody binds to and damages brain cells that are known to be important to neurological function, according to the study. Although the research is preliminary, experts say the findings may open the door for a blood test that could more easily diagnosis multiple sclerosis patients. The results also suggest a new target for MS treatments that would prevent the antibody from binding to brain cells. More

Anti-EGFR agents: Not first choice as mCRC first-line
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The NORDIC-VII multicenter phase 3 trial evaluated whether the anti-epidermal growth factor receptor antibody cetuximab enhanced efficacy when added to bolus fluorouracil/folinic acid and oxaliplatin, administered continuously or intermittently, in first-line metastatic colorectal cancer. Patients were randomly assigned to receive either standard Nordic FLOX, cetuximab and FLOX, or cetuximab combined with intermittent FLOX. More

Doctors: Mystery illness in Cambodia solved
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefThe cause of a mysterious illness that has claimed the lives of more than 60 Cambodian children has been determined, medical doctors familiar with the investigation told CNN. A combination of pathogens, disease-causing micro-organisms, is to blame for the illness, the World Health Organization, in conjunction with the Cambodian Ministry of Health, has concluded, the doctors said. More

Creative Laboratory Products

Based in Indianapolis, we create our products in FDA licensed laboratories to ensure the highest quality possible. We provide fast solutions for customer's individual lipid additives. Click here to learn more.

Will LFR sequencing enable full haplotype determination in the clinic?
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Complete Genomics has published data demonstrating the use of its long-fragment repeat technology for whole-genome sequencing and haplotyping using just 10–20 human cells, or about 120 picograms of high molecular mass DNA. The technology, which the firm claims is at least 10-fold more accurate than any existing high-sensitivity method, enables full haplotype determination, or phasing, to sequence maternal and paternal chromosomes separately and thus identify whether two genetic variants within a single gene are both carried on the same or different homologous chromosomes. More

Procedural simplicity
Advance    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Clinical Laboratory Improvement Amendments define categories of testing based on complexity. Waived tests are determined by the U.S. Food and Drug Administration as being "simple with a low risk of error," while non-waived tests are moderately or highly complex. Your procedures may mirror complexity, but simplicity with a low risk of error is always desirable. More

CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit

Researchers unravel secrets of parasites' replication
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A team of microbiologists at the University of Massachusetts Amherst has made an advance that could one day lead to a new weapon for fighting parasitic diseases such as African sleeping sickness, chagas disease and leishmaniasis. In Eukaryotic Cell, parasitologists Michele Klingbeil, doctoral candidate Jeniffer Concepción-Acevedo and colleagues report the first detailed characterization of the way key proteins in the model parasite Trypanosoma brucei organize to replicate its mitochondrial DNA. More

Studies examine risk of poor birth outcomes, nervous system disorder following H1N1 vaccination
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In studies examining the risk of adverse outcomes after receipt of the influenza A(H1N1) vaccine, infants exposed to the vaccine in utero did not have a significantly increased risk of major birth defects, preterm birth or fetal growth restriction; while in another, study researchers found a small increased risk in adults of the nervous system disorder, Guillain-Barre syndrome, during the four to eight weeks after vaccination, according to two studies in The Journal of the American Medical Association. More

Linking public health agencies, hospitals for improved emergency preparedness
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In 2003, 11 public health epidemiologists were placed in North Carolina's largest hospitals to enhance communication between public health agencies and healthcare systems for improved emergency preparedness. A report describes the specific services public health epidemiologists provide to local health departments, the North Carolina Division of Public Health, and the hospitals in which they are based, and assesses the value of these services to stakeholders. More

We've teamed up to save you even more on car insurance.

Find out if you're eligible for exclusive GEICO savings by starting a rate quote now – just make sure you select your group affiliation when asked.
JoinYour Peers

Many employers now require certification because they know that individuals who are certified are committed to their profession and to quality patient care. Learn how we can help!

Hepatitis C virus more frequent among African-Americans and males
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Epidemiologists have determined that levels of hepatitis C virus found among injection drug users were higher in individuals who are male or African-American even after differences in other factors were considered. The study, which was funded by the National Cancer Institute and performed with collaborators from the National Institutes of Health Clinical Center and the University of California - San Francisco, was the first to simultaneously examine the association of demographic, viral and human genetic factors on HCV RNA levels. More

Gene that fights Alzheimer's may inspire new treatments
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A gene that causes the rare, early-onset form of Alzheimer's disease can also carry a mutation that produces the opposite effect, staving off the devastating illness, scientists announced. The finding, published in the journal Nature, suggests that new drugs that mimic the mutation's effect could do the same, researchers said. More

HIV prophylaxis for heterosexuals: Conflicting trial results
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
HIV prophylaxis with tenofovir disoproxil fumarate alone or in combination with emtricitabine, together with counseling and other preventive measures, appears to effectively combat HIV transmission in heterosexuals, according to the findings of three randomized controlled trials. The findings of one of the trials, however, highlighted potential problems with patient compliance. The FEM-PReP Study Group, TDF2 Study Group, and Partners PReP Study Team presented their findings in separate articles published in the New England Journal of Medicine. More

Expand your career as a Clinical Lab Scientist at UCSF Medical Center.

Opportunities available in San Francisco, CA in various areas - Chemistry, Hematology, Blood Bank, Immunology, Microbiology, Molecular Diagnostics, Bone Marrow Transplant, and Cytogenetics. Apply online or contact Cheryl Hardin at for more information. EOE.

Computer model could aid cyberwarfare, conservation, disease prevention
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A computer model developed at the University of Missouri could help military strategists devise the most damaging cyber attacks as well as guard America's critical infrastructure. The model also could benefit other projects involving interconnected groups, such as restoring ecosystems, halting disease epidemics and stopping smugglers. More

Myelodysplastic syndrome linked to abnormal stem cells
HealthDay    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As researchers suspected, abnormal bone marrow stem cells trigger the development of myelodysplastic syndromes, serious blood diseases that affect the bone marrow and can progress to leukemia, according to a new study. The new findings, published in the July 2 online edition of Blood, could lead to improved treatments for myelodysplastic syndrome and cancers related to the syndrome, researchers from the Albert Einstein College of Medicine of Yeshiva University, in New York City, suggested in an Einstein news release. More

ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

July 17, 2012
July 10, 2012
July 3, 2012
June 26, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063